Hydroxychloroquine
CAS No. 118-42-3
Hydroxychloroquine( —— )
Catalog No. M23351 CAS No. 118-42-3
Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 35 | In Stock |
|
| 200MG | 50 | In Stock |
|
| 500MG | 82 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxychloroquine
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9.
-
DescriptionHydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR7/9
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number118-42-3
-
Formula Weight335.87
-
Molecular FormulaC18H26ClN3O
-
Purity>98% (HPLC)
-
Solubility1M HCl : 99 mg/mL (294.75 mM; adjust pH to 2 with HCl); H2O : 1.65 mg/mL (4.91 mM; ultrasonic and warming and heat to 60°C); DMSO : < 1 mg/mL (insoluble or slightly soluble)
-
SMILESCCN(CCCC(C)Nc1c(ccc(Cl)c2)c2ncc1)CCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf. 2017 Mar;16(3):411-419.
molnova catalog
related products
-
CU-CPT-8m
CU-CPT-8m is an toll-like receptor 8 (TLR8) antagonist (IC50 : 67 nM).
-
TLR7/8 agonist 1
TLR7/8 agonist 1 is a toll-like receptor TLR7/TLR8 agonist with anticancer and antiviral activities and can be used to study immune-related diseases.
-
TLR7/8-IN-1
TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.
Cart
sales@molnova.com